Home / Health / Queensland researchers in the massive development of Covid-19 as they find a way to kill 99.9% of the virus.

Queensland researchers in the massive development of Covid-19 as they find a way to kill 99.9% of the virus.



The next best thing to a cure: Queensland researchers on the massive development of Covid-19 as they find a way to kill 99.9% of the virus in people’s lungs.

  • Australian scientists have developed innovative treatments to stop the coronavirus.
  • Antiviral therapy has been proven to kill 99 percent of the virus in the lungs.
  • The technology works using an RNA drug called gene inhibition.

Antiretroviral therapy that kills 99.9 percent of COVID-19 in the lungs is being hailed as the next-best treatment.

The ‘next-generation’ technology works like a ‘heat-seeking missile’ to detect particles and attack them, developed by an international team of Australian scientists. Menzies Health Institute Queensland at Griffith University

Professor Nigel McMillan, a co-investigator at MHIQ, said the breakthrough treatment could prevent the virus from spreading and could halt COVID-related deaths worldwide.

Professor Kevin Morris (left), Dr. Adi Idris (second left), Professor Nigel Macmillan (center), Dr. Aaron Supramanin (second right). And Yusiv Idress (right) is part of Griffith University's COVID-19 virus research team.

Professor Kevin Morris (left), Dr. Adi Idris (second left), Professor Nigel Macmillan (center), Dr. Aaron Supramanin (second right). And Yusiv Idress (right) is part of Griffith University’s COVID-19 virus research team.

‘It’s basically a search and destruction mission,’ he said.

‘We can especially destroy viruses growing in someone’s lungs.’

It works using so-called medical technology. gene-Silencing Which was first discovered in Australia in the 1990s.

Gene muting uses RNA, a fundamental building block in the body, similar to DNA, to attack respiratory disease.

“This is a technology that works in conjunction with a tiny piece of RNA that can bind to a particular viral genome,” Professor McMillan said.

‘This binding keeps the genome inactive, and in fact causes cells to destroy it.’

'It's basically a search and destruction mission,' said Professor McMillan.  'We can especially destroy a virus that grows in someone's lungs.'

‘It’s basically a search and destruction mission,’ said Professor McMillan. ‘We can especially destroy viruses growing in someone’s lungs.’

Image: Image shows that RNA drugs can stop the COVID-19 virus from replicating.

Image: Image shows that RNA drugs can stop the COVID-19 virus from replicating.

There are, though, other antiretroviral therapy such as Zanamivir and Remdesivir that reduce symptoms and help coronavirus patients recover faster. But this is the first treatment to stop the virus directly.

Need to send medicine Into the bloodstream by injecting so-called ‘nanoparticles’.

‘These nanoparticles go to the lungs and fuse with RNA-transmitting cells,’ said Professor McMillan.

‘RNA searches for viruses and destroys their genomes, so viruses can no longer replicate.’

Scientists have been working on the treatment since April last year as Australia was ordered to shut down the nationwide system for six weeks.

More than 165 million people have been infected with the coronavirus, including 3.4 million deaths worldwide since the virus. First happened in December 2019 in Wuhan.

The University of Griffith treatment is currently slated for the next phase of clinical trials and is expected to be available by 2023.

Scientists have been operating treatment since April last year as Australia has been ordered to shut down a nationwide system for six weeks.Photo: Pfizer vaccine technician at the newly opened COVID-19 vaccination center in Sydney.

Scientists have been operating treatment since April last year as Australia has been ordered to shut down a nationwide system for six weeks.Photo: Pfizer vaccine technician at the newly opened COVID-19 vaccination center in Sydney.

The University of Griffith treatment is currently slated for the next phase of clinical trials and is expected to be available by 2023.Photo: Pfizer vaccine technician at the COVID-19 Vaccination Center at Newly opened in Sydney

The University of Griffith treatment is currently slated for the next phase of clinical trials and is expected to be available by 2023.Photo: Pfizer vaccine technician at the COVID-19 Vaccination Center at Newly opened in Sydney

Advertising


Source link